MedTrace Logo

Tracheobronchial Secretion Removal

NCT00932776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2009-07-03

No results posted yet for this study

Summary

Patients undergoing intubation and mechanical ventilation require removal of secretion by means of trachoebronchial suctioning. Timing of the procedure is mainly based on clinical parameters. TBA Care® is a new commercially available device designed to generate a signal when secretions are present in the respiratory tract of intubated patients, thus indicating the need for endotracheal suctioning only when necessary and prior to clinical deterioration. In a prospective randomized trial in intubated and mechanically ventilated patients of a general ICU the researchers investigated the efficacy of TBA Care® in detecting the presence of retained secretions compared to the standard indicators.

Conditions

  • Respiration, Artificial
  • Respiratory Insufficiency

Interventions

DEVICE

TBA care device

Tracheal suction maneuvers are performed according to the indications provided by the TBA care device or to clinical parameters whichever occurs first.

DEVICE

Control

In this group suction maneuvers are performed according to clinical indications or on a fixed schedule whichever comes first.

Sponsors & Collaborators

  • University of Milano Bicocca

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00932776 on ClinicalTrials.gov